Suppr超能文献

RACK1与HSP90竞争结合HIF-1α,并且是HIF-1α的不依赖氧和HSP90抑制剂诱导降解所必需的。

RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha.

作者信息

Liu Ye V, Baek Jin H, Zhang Huafeng, Diez Roberto, Cole Robert N, Semenza Gregg L

机构信息

Vascular Biology Program, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

出版信息

Mol Cell. 2007 Jan 26;25(2):207-17. doi: 10.1016/j.molcel.2007.01.001.

Abstract

Hypoxia-inducible factor 1 (HIF-1) regulates transcription in response to changes in O(2) concentration. O(2)-dependent degradation of the HIF-1alpha subunit is mediated by prolyl hydroxylase (PHD), the von Hippel-Lindau (VHL)/Elongin-C/Elongin-B E3 ubiquitin ligase complex, and the proteasome. Inhibition of heat-shock protein 90 (HSP90) leads to O(2)/PHD/VHL-independent degradation of HIF-1alpha. We have identified the receptor of activated protein kinase C (RACK1) as a HIF-1alpha-interacting protein that promotes PHD/VHL-independent proteasomal degradation of HIF-1alpha. RACK1 competes with HSP90 for binding to the PAS-A domain of HIF-1alpha in vitro and in human cells. HIF-1alpha degradation induced by the HSP90 inhibitor 17-allylaminogeldanamycin is abolished by RACK1 loss of function. RACK1 binds to Elongin-C and promotes ubiquitination of HIF-1alpha. Elongin-C-binding sites in RACK1 and VHL show significant sequence similarity. Thus, RACK1 is an essential component of an O(2)/PHD/VHL-independent mechanism for regulating HIF-1alpha stability through competition with HSP90 and recruitment of the Elongin-C/B ubiquitin ligase complex.

摘要

缺氧诱导因子1(HIF-1)可根据氧浓度的变化调节转录。HIF-1α亚基的氧依赖性降解由脯氨酰羟化酶(PHD)、冯·希佩尔-林道(VHL)/延伸蛋白C/延伸蛋白B E3泛素连接酶复合物和蛋白酶体介导。抑制热休克蛋白90(HSP90)会导致HIF-1α发生不依赖氧/PHD/VHL的降解。我们已确定活化蛋白激酶C受体(RACK1)是一种与HIF-1α相互作用的蛋白,可促进HIF-1α发生不依赖PHD/VHL的蛋白酶体降解。在体外和人类细胞中,RACK1与HSP90竞争结合HIF-1α的PAS-A结构域。RACK1功能缺失可消除HSP90抑制剂17-烯丙基氨基格尔德霉素诱导的HIF-1α降解。RACK1与延伸蛋白C结合并促进HIF-1α的泛素化。RACK1和VHL中的延伸蛋白C结合位点显示出显著的序列相似性。因此,RACK1是通过与HSP90竞争并募集延伸蛋白C/B泛素连接酶复合物来调节HIF-1α稳定性的不依赖氧/PHD/VHL机制的重要组成部分。

相似文献

2
RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization.
Cell Cycle. 2007 Mar 15;6(6):656-9. doi: 10.4161/cc.6.6.3981. Epub 2007 Mar 7.
3
Calcineurin promotes hypoxia-inducible factor 1alpha expression by dephosphorylating RACK1 and blocking RACK1 dimerization.
J Biol Chem. 2007 Dec 21;282(51):37064-73. doi: 10.1074/jbc.M705015200. Epub 2007 Oct 26.
5
COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90/70.
PLoS One. 2009 Oct 5;4(10):e7332. doi: 10.1371/journal.pone.0007332.
8
Hypoxia-inducible factor 1 (HIF-1) pathway.
Sci STKE. 2007 Oct 9;2007(407):cm8. doi: 10.1126/stke.4072007cm8.
10
PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation.
J Biol Chem. 2004 Apr 2;279(14):13506-13. doi: 10.1074/jbc.M310164200. Epub 2004 Jan 15.

引用本文的文献

2
RACK1 promotes the development and function of alveolar macrophages through directly binding to and stabilizing PPARγ.
Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2421672122. doi: 10.1073/pnas.2421672122. Epub 2025 Jun 13.
3
The Distinct Role of HIF-1α and HIF-2α in Hypoxia and Angiogenesis.
Cells. 2025 May 4;14(9):673. doi: 10.3390/cells14090673.
5
HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects.
Cell Mol Life Sci. 2025 Jan 18;82(1):44. doi: 10.1007/s00018-024-05537-0.
7
Targeting CDK2 Confers Vulnerability to Lenvatinib Via Driving Senescence in Anaplastic Thyroid Cancer.
Adv Sci (Weinh). 2025 Feb;12(7):e2413514. doi: 10.1002/advs.202413514. Epub 2024 Dec 24.
8
A closer look at the role of deubiquitinating enzymes in the Hypoxia Inducible Factor pathway.
Biochem Soc Trans. 2024 Dec 19;52(6):2253-2265. doi: 10.1042/BST20230861.
10
Hypoxia-inducible transcription factors: architects of tumorigenesis and targets for anticancer drug discovery.
Transcription. 2025 Feb;16(1):86-117. doi: 10.1080/21541264.2024.2417475. Epub 2024 Oct 29.

本文引用的文献

1
Inhibitors of the HSP90 molecular chaperone: current status.
Adv Cancer Res. 2006;95:323-48. doi: 10.1016/S0065-230X(06)95009-X.
2
Hsp90: a novel target for cancer therapy.
Curr Top Med Chem. 2006;6(11):1205-14. doi: 10.2174/156802606777812068.
3
HIF-1 and tumour radiosensitivity.
Br J Cancer. 2006 Jul 3;95(1):1-5. doi: 10.1038/sj.bjc.6603201. Epub 2006 May 30.
5
HSP90 and the chaperoning of cancer.
Nat Rev Cancer. 2005 Oct;5(10):761-72. doi: 10.1038/nrc1716.
6
RACK1 mediates activation of JNK by protein kinase C [corrected].
Mol Cell. 2005 Aug 5;19(3):309-20. doi: 10.1016/j.molcel.2005.06.025.
7
Hypoxia preconditioning in the brain.
Dev Neurosci. 2005 Mar-Aug;27(2-4):87-92. doi: 10.1159/000085979.
10
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1.
Blood. 2005 Jan 15;105(2):659-69. doi: 10.1182/blood-2004-07-2958. Epub 2004 Sep 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验